13 | Capsaicin (Zostrix)FDA Link
01/2020
-
04/2001 |
11 | CannabinoidsIBA
09/2017
-
09/2001 |
10 | Opioid Analgesics (Opioids)IBA
01/2023
-
07/2011 |
7 | Analgesics (Analgesic Drugs)IBA
09/2023
-
06/2010 |
7 | EndocannabinoidsIBA
01/2023
-
10/2008 |
7 | Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
11/2017
-
10/2002 |
7 | Cannabinoid Receptor AgonistsIBA
02/2012
-
05/2003 |
6 | anandamide (arachidonylethanolamide)IBA
09/2017
-
10/2008 |
5 | Cisplatin (Platino)FDA LinkGeneric
01/2023
-
05/2012 |
5 | LigandsIBA
01/2020
-
05/2003 |
5 | Morphine (MS Contin)FDA LinkGeneric
12/2019
-
07/2010 |
4 | Freund's AdjuvantIBA
09/2023
-
11/2008 |
3 | EnzymesIBA
12/2023
-
10/2008 |
3 | hemoglobin AAIBA
11/2023
-
01/2019 |
3 | mu Opioid Receptors (mu Opioid Receptor)IBA
10/2020
-
11/2019 |
3 | cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
09/2017
-
10/2008 |
3 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
09/2011
-
06/2004 |
3 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
09/2011
-
09/2001 |
3 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
06/2008
-
09/2001 |
2 | Hemoglobin AIBA
11/2023
-
07/2010 |
2 | Sickle HemoglobinIBA
01/2023
-
07/2010 |
2 | glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
01/2023
-
01/2019 |
2 | EstersIBA
01/2023
-
05/2012 |
2 | Dinoprostone (PGE2)FDA Link
01/2023
-
01/2019 |
2 | ProstaglandinsIBA
01/2023
-
01/2019 |
2 | PlatinumIBA
11/2019
-
03/2015 |
2 | MCC22IBA
11/2019
-
07/2018 |
2 | Histamine (Histamine Dihydrochloride)FDA Link
01/2018
-
01/2004 |
2 | Substance PIBA
09/2013
-
09/2008 |
2 | 3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA
02/2012
-
07/2010 |
2 | CB2 Cannabinoid ReceptorIBA
09/2011
-
07/2011 |
2 | Proteins (Proteins, Gene)FDA Link
07/2011
-
10/2008 |
2 | Messenger RNA (mRNA)IBA
10/2008
-
09/2007 |
2 | Peptides (Polypeptides)IBA
10/2008
-
09/2007 |
2 | Cytotoxins (Cytolysins)IBA
02/2005
-
10/2002 |
2 | substance P-saporinIBA
02/2005
-
10/2002 |
2 | CarrageenanIBA
05/2003
-
05/2003 |
2 | RimonabantIBA
05/2003
-
09/2001 |
1 | lysophosphatidic acidIBA
12/2023 |
1 | Lysophosphatidic Acid ReceptorsIBA
12/2023 |
1 | Complement System Proteins (Complement)IBA
11/2023 |
1 | Monoclonal AntibodiesIBA
11/2023 |
1 | JZL 184IBA
01/2023 |
1 | Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2023 |
1 | Lidocaine (Xylocaine)FDA LinkGeneric
01/2023 |
1 | Methylene Blue (Methylthioninium Chloride)FDA Link
01/2022 |
1 | Cyanides (Isocyanides)IBA
01/2022 |
1 | IfosfamideFDA LinkGeneric
01/2022 |
1 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2021 |
1 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 |
1 | AntioxidantsIBA
01/2021 |
1 | resolvin D1IBA
12/2020 |
1 | 5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA
12/2020 |
1 | Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
12/2020 |
1 | oxymorphindoleIBA
10/2020 |
1 | Loperamide (Imodium)FDA LinkGeneric
10/2020 |
1 | delta Opioid Receptors (delta Opioid Receptor)IBA
10/2020 |
1 | Insulin-Like PeptidesIBA
01/2020 |
1 | BaclofenFDA LinkGeneric
01/2020 |
1 | Metabotropic Glutamate 5 ReceptorIBA
01/2020 |
1 | Antineoplastic Agents (Antineoplastics)IBA
11/2019 |
1 | Chemokine ReceptorsIBA
11/2019 |
1 | Pioglitazone (Actos)FDA Link
03/2019 |
1 | Hypoglycemic Agents (Hypoglycemics)IBA
03/2019 |
1 | CalciumIBA
03/2019 |
1 | purinoceptor P2Y6IBA
01/2019 |
1 | Oxygen (Dioxygen)IBA
01/2019 |